Skip Navigation LinksHome > December 2006 - Volume 49 - Issue 4 > Thrombophilia and Adverse Maternal-Perinatal Outcome
Clinical Obstetrics & Gynecology:
doi: 10.1097/01.grf.0000211954.66959.e1
Thrombotic Disorders

Thrombophilia and Adverse Maternal-Perinatal Outcome

STELLA, CAROLINE L. MD; SIBAI, BAHA M. MD

Collapse Box

Abstract

A recent review of the literature on thrombophilia and adverse pregnancy outcome (APO) reveals contradictory findings. We have limited our review of literature mostly to the most recent decade. On the basis of our review, screening for thrombophilias with a history of APO (preeclampsia, abruptio placenta, intrauterine growth restriction, and fetal loss) is not clear. There are retrospective and prospective studies that recommend testing for genetic and acquired markers of thrombophilia for those with the enumerated APO. The rationale for such recommendation is to use heparin prophylaxis in subsequent pregnancies. However, this recommendation is not based on randomized trials. Hence, a randomized double-blinded controlled trial is urgently needed to evaluate the benefit of heparin during pregnancy in women with a history of APO in association with thrombophilia.

© 2006 Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.